98%
921
2 minutes
20
Comparing data from different years and the time of year during which data are collected can affect respondents' answers or health status. This study investigated the possible association between seasonality and the self-reported health-related quality of life (HRQoL) of patients with coronary artery disease (CAD) during rehabilitation and at a 2-year follow-up. The study included 1026 respondents (79% men; mean age 56 ± 9 years). Baseline characteristics covered socio-demographic, clinical factors, and psychological assessments using the Hospital Anxiety and Depression Scale. HRQoL was evaluated using the 36-item Short Form Medical Outcome Questionnaire (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The MLHFQ data were collected longitudinally. The results of the multivariable linear regression confirmed a potential association between seasonality and self-reported HRQoL as assessed during cardiac rehabilitation period in patients with CAD. According to the SF-36, the summer season was associated with improved mental health outcomes, while the winter season was significantly linked to better scores in the pain domain. Based on the MLHFQ data, the winter season was associated with better overall HRQoL both during rehabilitation and at the 2-year follow-up. Similarly, the MLHFQ physical dimension showed better scores in winter at the 2-year follow-up, but not at baseline.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043977 | PMC |
http://dx.doi.org/10.1038/s41598-025-99478-8 | DOI Listing |
Jpn J Ophthalmol
September 2025
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto City, Kyoto Prefecture, 606-8507, Japan.
Purpose: To identify predictors of the 2-year best-corrected visual acuity (BCVA) after subretinal tissue plasminogen activator (tPA) injection for massive submacular hemorrhage (SMH) complicating neovascular age-related macular degeneration (nAMD).
Study Design: A prospective, observational study.
Methods: This study included consecutive eyes with massive SMH and nAMD that underwent vitrectomy with subretinal tPA injection and follow-up for 2 years.
Orbit
September 2025
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
VEXAS syndrome is a rare disorder marked by systemic inflammation and blood disorders, caused by somatic mutations in the gene of hematopoietic stem cells. Ocular manifestations are common in VEXAS syndrome. This study reports a 63-year-old male presenting with recurrent periorbital and orbital inflammation, dacryoadenitis, and orbital myositis.
View Article and Find Full Text PDFPurpose: Knee osteoarthritis (OA) is the most common degenerative joint disease in the world. It results in not only physical limitation and pain, but also negatively impacts quality of life and mental wellbeing. Treatment options such as medial opening wedge high tibial osteotomy (MOWHTO) help to relieve pain and improve functionality, but there is limited literature on the effect on mental health.
View Article and Find Full Text PDFCase Rep Orthop
August 2025
Department of Orthopaedic Surgery, Nishinomiya Kaisei Hospital, Nishinomiya, Hyogo, Japan.
In recent decades, arthroscopic meniscal repair has been increasingly indicated for meniscal tears in the last decades. Although literature generally reports favorable surgical outcomes, it remains unclear whether the repaired meniscus maintains its function over the long term while performing its chondroprotective function without recurrent tear after clinical healing. A 43-year-old Japanese man who underwent meniscal repair for a bucket handle tear of the medial meniscus (MM) at the age of 15 years presented with right knee pain and catching symptoms without a preceding traumatic event.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Hematology, General Hospital of the Northern Theater Command, Shenyang, China.
Objective: Chimeric antigen receptor T-cell immunotherapy (CAR-T) is a preferred treatment for relapsed or refractory (R/R) large B-cell lymphoma (LBCL). Several trials have evaluated CD20×CD3 bispecific antibodies (BsAbs) as subsequent therapy in R/R LBCL. This study aimed to investigate the efficacy of CD20×CD3 BsAbs (mosunetuzumab, glofitamab, odronextamab, and epcoritamab) in patients with LBCL who experienced relapse or refractory disease following CAR-T therapy.
View Article and Find Full Text PDF